Anti-TNF therapies may reduce Alzheimer’s risk among people who have rheumatoid arthritis Anti-TNF therapies commonly used to take care of rheumatoid arthritis have already been found to potentially reduce the threat of developing Alzheimer’s dementia among people who have rheumatoid arthritis, according to analyze presented this complete week in the American College of Rheumatology Annual Scientific Getting together with in Atlanta estrogen pituitary tumor . Rheumatoid arthritis is normally a chronic disease that triggers discomfort, stiffness, swelling, and destruction of the joints. People with RA often knowledge limitation in the motion and function of multiple joints.
‘The wealth of brand-new information released in the last year regarding the treating SLE and BAFF inhibition provides an excellent possibility to re-evaluate how we consider SLE, from optimum trial design to improving patient selection,’ stated Dr. Colin Hislop, Anthera's Chief Medical Officer. ‘We look forward to having top experts in the field give us their views on what recent developments mean for patients with lupus.’.. Anthera Pharmaceuticals to sponsor Lupus symposium in San Francisco Anthera Pharmaceuticals, Inc. today announced that it is inviting its shareholders and investors to a symposium on Systemic Lupus Erythematosus at 3:30 PM on Wednesday, 14th at the Mystic Hotel in SAN FRANCISCO BAY AREA January, CA. David Wofsy, Dr. Joan Merrill, and Dr. Vibeke Strand, to provide their perspectives on latest developments in the treatment of BAFF and SLE inhibition.